TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8865110

Group type: EXPERIMENTAL
Intervention: Dipeptide-containing solution (glycyl-glutamine/glycyl-tyrosine) infused at 0.60 mL/h/kg; 82.2 mg total dipeptides/amino acids/h/kg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional amino acid solutions infused at 0.73 mL/h/kg; 83.2 mg total amino acids/h/kg
Number of subjects: 15
Study: 1633724

Group type: EXPERIMENTAL
Intervention: Controlled-release indomethacin (75 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 6338800

Group type: EXPERIMENTAL
Intervention: Ethamsylate intravenously prior to induction of anaesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no ethamsylate)
Number of subjects: 60
Study: 31064361

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg
Number of subjects: 1544

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg
Number of subjects: 1544

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1544
Study: 28168513

Group type: EXPERIMENTAL
Intervention: CMR participants
Number of subjects: 92

Group type: COMPARATOR
Intervention: CMR drop-outs
Number of subjects: 92
Study: 26415738

Group type: EXPERIMENTAL
Intervention: Active intervention group received the CPD outcomes framework and associated training.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group received information on new CPD requirements through the post.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Active intervention group with rewritten records.
Number of subjects: 48
Study: 22465984

Group type: EXPERIMENTAL
Intervention: High-velocity training
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 19
Study: 21958928

Group type: EXPERIMENTAL
Intervention: Video-reminded group (received a memory card with a video clip about CPR and AED use)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Video-reminded group
Number of subjects: 75
Study: 19430350

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Combination of losartan and nebivolol
Number of subjects: 291

Group type: COMPARATOR
Intervention: Losartan and Nebivolol
Number of subjects: 291
Study: 16963731

Group type: EXPERIMENTAL
Intervention: Gefitinib (250 or 500 mg/d)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 70
Study: 16831672

Group type: EXPERIMENTAL
Intervention: Cyclosporine (68 patients)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Steroid (71 patients)
Number of subjects: 139
Study: 9895078

Group type: EXPERIMENTAL
Intervention: 20 mL of 1% lidocaine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 10 mL of 2% lidocaine
Number of subjects: 20
Study: 8840367

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers, digoxin, and beta-blockers (specific dosages and duration not provided)
Number of subjects: 0
Study: 2000267

Group type: EXPERIMENTAL
Intervention: Balanced education program (lectures and handouts)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Risks-only (negative or 'scare tactics') presentation
Number of subjects: 0
Study: 6133056

Group type: EXPERIMENTAL
Intervention: Single-dose therapy with chloroquine (10 mg base/kg)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Standard therapeutic regimen of chloroquine (25 mg base/kg)
Number of subjects: 54

Group type: COMPARATOR
Intervention: In-vitro testing of chloroquine resistance
Number of subjects: 54
Study: 30929491

Group type: EXPERIMENTAL
Intervention: Implant Removal (IR)
Number of subjects: 179
Study: 29741133

Group type: EXPERIMENTAL
Intervention: PA-coated components
Number of subjects: 60

Group type: COMPARATOR
Intervention: Uncoated components
Number of subjects: 60
Study: 27485577

Group type: EXPERIMENTAL
Intervention: Long-detection interval (LDI)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Anti-tachycardia pacing (ATP)
Number of subjects: 220
Study: 24357853

Group type: EXPERIMENTAL
Intervention: Serum CTRP9 concentrations
Number of subjects: 221
Study: 22609423

Group type: EXPERIMENTAL
Intervention: Pomegranate juice (100 cc, three times a week for 1 year)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Pomegranate juice
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 20638818

Group type: EXPERIMENTAL
Intervention: 5-FU (5-fluorouracil)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: CDDP (cisplatin)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 5-FU + CDDP
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no chemotherapy)
Number of subjects: 63
Study: 18402856

Group type: EXPERIMENTAL
Intervention: Contraceptive counseling and educational leaflets in the postnatal ward after delivery
Number of subjects: 600

Group type: COMPARATOR
Intervention: No formal contraceptive advice (Control group)
Number of subjects: 600
Study: 15837864

Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream
Number of subjects: 492

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 492
Study: 12211219

Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg) with aspirin (325 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo with aspirin (325 mg)
Number of subjects: 16
Study: 10478142

Group type: EXPERIMENTAL
Intervention: BB genotype
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: B allele and BB genotype
Number of subjects: 99

Group type: COMPARATOR
Intervention: b allele and bb genotype
Number of subjects: 99
Study: 8720887

Group type: EXPERIMENTAL
Intervention: Propofol 2 mg/kg for induction, 5-6 mg/kg.h for maintenance
Number of subjects: 230

Group type: COMPARATOR
Intervention: Enflurane 0.8%-1.5% for maintenance
Number of subjects: 230
Study: 1917320

Group type: EXPERIMENTAL
Intervention: Topical isosorbide-mononitrate (ISMO) 0.5% eye drops
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical isosorbide-mononitrate (ISMO) 2% eye drops
Number of subjects: 0
Study: 31892336

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitor (AI) therapy for 2 weeks
Number of subjects: 254

Group type: COMPARATOR
Intervention: No presurgical treatment (control)
Number of subjects: 254
Study: 29319719

Group type: EXPERIMENTAL
Intervention: Low-cost negative-pressure wound therapy (USP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercially available therapy device (VAC)
Number of subjects: 0
Study: 25249320

Group type: COMPARATOR
Intervention: Corticosteroid
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Cryopreserved human amniotic membrane (c-hAM)
Number of subjects: 23
Study: 23612436

Group type: EXPERIMENTAL
Intervention: Methylphenidate (Ritalin, 20 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 21865456

Group type: EXPERIMENTAL
Intervention: Processing Speed Training
Number of subjects: 0
Study: 19365873

Group type: EXPERIMENTAL
Intervention: Selenium-biofortified wheat (3 puffed wheat biscuits/day providing 267 microg Se)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Selenium-biofortified wheat
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 62
Study: 17053854

Group type: EXPERIMENTAL
Intervention: Acquiring syringes through a safe source
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Visiting a syringe exchange program
Number of subjects: 680

Group type: COMPARATOR
Intervention: Living in San Francisco
Number of subjects: 680

Group type: COMPARATOR
Intervention: Less frequent binge drinking
Number of subjects: 680

Group type: COMPARATOR
Intervention: Injecting with an HIV+ partner
Number of subjects: 680

Group type: COMPARATOR
Intervention: Peer norms supporting safe injection
Number of subjects: 680

Group type: COMPARATOR
Intervention: Self-empowerment
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Being from New York
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Being older
Number of subjects: 680
Study: 15157729

Group type: EXPERIMENTAL
Intervention: Lifestyle Program (6-month behavioral skills training group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Educational Support Program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 0
Study: 11197295

Group type: EXPERIMENTAL
Intervention: Total colonic decompression
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (no decompression)
Number of subjects: 126
Study: 9883955

Group type: EXPERIMENTAL
Intervention: Manual therapy programme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive training programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: General practitioner programme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study: 8083146

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) at doses of 5 mg, 10 mg, 15 mg, and 20 mg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 76
Study: 2492893

Group type: EXPERIMENTAL
Intervention: Etidronate disodium 400 mg daily for 3 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Etidronate disodium (after stopping therapy)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oophorectomy (surgical menopause)
Number of subjects: 20
Study: 4851464

Group type: EXPERIMENTAL
Intervention: DDAVP (1-desamino-8-D-arginine vasopressin)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Intranasal DDAVP (twice-daily)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Intramuscular DDAVP (single daily injections)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Lysine vasopressin
Number of subjects: 11
Study: 31663925

Group type: EXPERIMENTAL
Intervention: Patient-specific, dynamic Bayesian model predicting severe oliguria
Number of subjects: 3370

Group type: COMPARATOR
Intervention: Kidney Disease: Improving Global Outcomes urine output criterion for acute kidney injury
Number of subjects: 3370
Study: 30766457

Group type: EXPERIMENTAL
Intervention: Cerner EHR system
Number of subjects: 4

Group type: COMPARATOR
Intervention: Other EHR system (not specified)
Number of subjects: 4
Study: 27702805

Group type: EXPERIMENTAL
Intervention: Personalized booklet presenting melanoma genomic risk, telephone‐based genetic counseling, and nonpersonalized educational materials.
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (nonpersonalized educational materials).
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Intervention group (personalized booklet and counseling).
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Intervention and control groups.
Number of subjects: 118
Study: 25254570

Group type: EXPERIMENTAL
Intervention: Massage with rose oil
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo with unscented almond oil
Number of subjects: 75

Group type: COMPARATOR
Intervention: No treatment control (just self-massage)
Number of subjects: 75
Study: 23341486

Group type: EXPERIMENTAL
Intervention: Strontium ranelate at 2 g/d (n = 174)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo (n = 87)
Number of subjects: 261
Study: 21697540

Group type: EXPERIMENTAL
Intervention: NUTRIOSE 10 (resistant dextrin)
Number of subjects: 12

Group type: COMPARATOR
Intervention: maltodextrin
Number of subjects: 12
Study: 18289898

Group type: EXPERIMENTAL
Intervention: Brinzolamide suspension, 1%, dosed twice daily
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Levobetaxolol suspension, 0.5%, dosed twice daily
Number of subjects: 78
Study: 16510487

Group type: EXPERIMENTAL
Intervention: Ecstasy users
Number of subjects: 46

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 46
Study: 14506909

Group type: EXPERIMENTAL
Intervention: Nimesulide 100mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diclofenac 50mg
Number of subjects: 20
Study: 10753273

Group type: EXPERIMENTAL
Intervention: Upper-limb training (n = 26)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Lower-limb training (n = 26)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Untrained control group (n = 15)
Number of subjects: 67
Study: 8827572

Group type: EXPERIMENTAL
Intervention: Induction with oxytocin
Number of subjects: 123

Group type: COMPARATOR
Intervention: Expectant care for 48 hours
Number of subjects: 123
Study: 1394814

Group type: EXPERIMENTAL
Intervention: Maintenance therapy consisting of monthly instillations of mitomycin C and doxorubicin for 12 months
Number of subjects: 101

Group type: COMPARATOR
Intervention: Non-maintenance group
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Intravesical combination chemotherapy (mitomycin C and doxorubicin)
Number of subjects: 101
Study: 3891833

Group type: EXPERIMENTAL
Intervention: Octopus 2000 R perimeter
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Friedmann Mark II Visual Fields Analyser
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Baylor visual fields programmer
Number of subjects: 50
Study: 30968572

Group type: EXPERIMENTAL
Intervention: IOL repositioning by scleral suturing
Number of subjects: 104

Group type: COMPARATOR
Intervention: IOL exchange with a retropupillary iris-claw lens
Number of subjects: 104
Study: 29567956

Group type: EXPERIMENTAL
Intervention: Pediococcus acidilactici K15
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27126154

Group type: EXPERIMENTAL
Intervention: Between-meal snacks
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Oral nutrition supplements (ONS)
Number of subjects: 247
Study: 24953578

Group type: EXPERIMENTAL
Intervention: Oral zinc sulfate (10 mg/d)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 22088820

Group type: EXPERIMENTAL
Intervention: NBCA adhesive
Number of subjects: 110

Group type: COMPARATOR
Intervention: Traditional suture
Number of subjects: 110
Study: 20977764

Group type: EXPERIMENTAL
Intervention: Extracorporeal focused shock wave therapy (2000 impulses, 0.25 mJ/m2 every 1-2 weeks) plus specific gluteal strength exercise training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham extracorporeal focused shock wave therapy (2000 impulses, 0.01 mJ/m2 every 1-2 weeks) plus specific gluteal strength exercise training
Number of subjects: 0
Study: 18927173

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg daily) plus antioxidant capsule
Number of subjects: 1276

Group type: COMPARATOR
Intervention: Aspirin (100 mg daily) plus placebo capsule
Number of subjects: 1276

Group type: EXPERIMENTAL
Intervention: Placebo tablet plus antioxidant capsule
Number of subjects: 1276

Group type: COMPARATOR
Intervention: Placebo tablet plus placebo capsule
Number of subjects: 1276
Study: 15887251

Group type: EXPERIMENTAL
Intervention: AC electric fields (up to 35 kV/m, frequency 60 Hz)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: AC electric fields limited to the dorsal forearm
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: AC electric fields limited to the hand (hairy or glabrous skin)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: AC electric fields with hair removed from forearm and hand
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DC electric fields (up to 65 kV/m)
Number of subjects: 16
Study: 11986099

Group type: EXPERIMENTAL
Intervention: Laser photocoagulation
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 66
Study: 9708873

Group type: EXPERIMENTAL
Intervention: Four food-frequency categories of fruit intake
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Dietary intake of fresh fruit (g/day)
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Dietary vitamin C intake (mg/day) measured by DR
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Use of vitamin C supplements
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Intake frequency of fruit
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Intake frequency of pickled vegetables
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Intake frequency of potatoes
Number of subjects: 621
Study: 7635771

Group type: EXPERIMENTAL
Intervention: Tpot measurements (flow cytometry)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Tumor size
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Tpot (1/Tpot)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Labeling Index (LI)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Overall Treatment Time (OTT)
Number of subjects: 46
Study: 2359302

Group type: EXPERIMENTAL
Intervention: Couples group therapy condition
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard individual therapy condition
Number of subjects: 16
Study: 314789

Group type: EXPERIMENTAL
Intervention: Pulsatile assist device (PAD)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nonpulsatile flow (Control)
Number of subjects: 100
Study: 30131583

Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment (exact dosage not specified)
Number of subjects: 11330

Group type: COMPARATOR
Intervention: Other tested potential risk factors (obesity, IPS, radiotherapy)
Number of subjects: 11330
Study: 29613819

Group type: EXPERIMENTAL
Intervention: Visualizations that augment perceptual processing and recognition memory
Number of subjects: 90

Group type: COMPARATOR
Intervention: Unaided team collaboration
Number of subjects: 90

Group type: COMPARATOR
Intervention: Participant teams discussing security incidents commonly known to the majority
Number of subjects: 90
Study: 26787505

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 4 mg/kg
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 8 mg/kg
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Combination of biomarkers
Number of subjects: 740

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 740
Study: 24588561

Group type: EXPERIMENTAL
Intervention: Exclusively human milk (EHM) diet
Number of subjects: 605

Group type: COMPARATOR
Intervention: Bovine-based milk products (control)
Number of subjects: 605
Study: 22437139

Group type: EXPERIMENTAL
Intervention: Effective CPAP
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: COMPARATOR
Intervention: OSA group
Number of subjects: 56
Study: 20965879

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 11325
Study: 17434829

Group type: EXPERIMENTAL
Intervention: Amoxicillin‐clavulanic acid (2.2 g)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Cefazolin (2 g)
Number of subjects: 178
Study: 15724911

Group type: EXPERIMENTAL
Intervention: Incidental encoding of temporal context; no specific dosage or duration mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intentional encoding of temporal context; no specific dosage or duration mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Retrieval of encoding context as a cue for list occurrence; no specific dosage or duration mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evaluating temporal distance from the strength of the memory trace; no specific dosage or duration mentioned.
Number of subjects: 0
Study: 12036809

Group type: EXPERIMENTAL
Intervention: High-fiber breakfast cereal (HF diet) for 6 months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Low-fiber breakfast cereal (LF diet) for 6 months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Monounsaturated fatty acids (MUFA diet) for 6 months
Number of subjects: 62
Study: 10402402

Group type: EXPERIMENTAL
Intervention: In-house Earle's balanced salt solution (EBSS)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Commercially prepared Earle's balanced salt solution (EBSS)
Number of subjects: 448
Study: 7720336

Group type: EXPERIMENTAL
Intervention: L-arginine (0.1 g/kg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: L-arginine (0.2 g/kg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 2035794

Group type: EXPERIMENTAL
Intervention: Subcutaneous wound infiltration with 20 ml of 0.5% bupivacaine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 7034564

Group type: EXPERIMENTAL
Intervention: Quinine plus a single dose of pyrimethamine‐sulfadoxine (Fansidar)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Quinine alone
Number of subjects: 52
Study: 31931923

Group type: EXPERIMENTAL
Intervention: Audiovisual distraction (AVD) using virtual reality device (VRZ4‐VRBOX)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical anesthesia (benzocaine gel) without audiovisual distraction (AVD)
Number of subjects: 50
Study: 30040008

Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation Therapy (VRT) in conjunction with cervical spine therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation Therapy (VRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation Therapy (VRT) in conjunction with light aerobic exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cervical spine therapy alone
Number of subjects: 0
Study: 29097927

Group type: EXPERIMENTAL
Intervention: 3D-PEM
Number of subjects: 410

Group type: COMPARATOR
Intervention: WBPET
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: 3D-PEM (after excluding patients with lesions beyond detecting range)
Number of subjects: 410

Group type: COMPARATOR
Intervention: WBPET (after excluding patients with lesions beyond detecting range)
Number of subjects: 410
Study: 25413267

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.4% infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 60
Study: 25042212

Group type: EXPERIMENTAL
Intervention: Quitline cessation counseling
Number of subjects: 512

Group type: COMPARATOR
Intervention: Self-help brochure
Number of subjects: 512
Study: 22795925

Group type: EXPERIMENTAL
Intervention: Ipragliflozin (300 mg qd)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 21165291

Group type: EXPERIMENTAL
Intervention: Enteric-coated mycophenolate sodium (EC‐MPS)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Overall Treatment Effect (OTE) for EC‐MPS
Number of subjects: 258